According to Bloomberg.com, the consensus recommendation among the 18 brokerage houses that follow 1Life Healthcare, Inc. (NASDAQ: ONEM) stock is to “Hold” the company’s shares. This evaluation pertains to the price of the company’s shares. Ten equity research experts have indicated that investors should maintain their current holdings of the shares, while five of the same analysts have indicated that investors should purchase the stock. The brokerage firms that rated the stock in the prior year believe that the company will achieve an average price goal of $20.46 in the stock market within the next twelve months.
The production of reports about the company has seen contributions from various research analysts on multiple occasions. In a research report that was made public on July 22, Piper Sandler indicated that the price objective for 1Life Healthcare had been raised to $18.00. The report was published on Friday. The “buy” recommendation Stifel Nicolaus had previously given to 1Life Healthcare was reduced to a “hold” rating in a research report on July 27. In a research report released on Tuesday, August 9, Evercore ISI raised their price target on 1Life Healthcare shares to $18.00 in a research report. The report was published in conjunction with the company’s earnings release. In a research note published on Friday, July 22, Deutsche Bank Aktiengesellschaft increased its price target on 1Life Healthcare shares from $12.00 to $18.00 in a research note. Finally, in a research note published on Friday, July 22, Citigroup raised its price target on 1Life Healthcare from $14.00 to $18.00 in a research note. This was the last but not the least of the changes. On the other hand, the rating for the company was altered from “buy” to “neutral.”
Several hedge funds and other types of institutional investors have made adjustments to the positions that they have held in ONEM throughout the past few weeks. Aaron Wealth Advisors LLC spent approximately 212,000 dollars over the first three months to acquire a new stake in 1Life Healthcare. Sandy Spring Bank could achieve a 125.4% increase in its ownership of 1Life Healthcare during the first three months of the year. Sandy Spring Bank increased the total number of shares it owned in the company during the most recent quarter by purchasing an additional 1,947 shares. This brought the total number of shares it owned in the company to 3,500, valued at $39,000. During the second quarter, CWM LLC achieved a 102.7% increase in the proportion of 1Life Healthcare stock it owned. CWM LLC made an additional purchase of 1,810 shares of company stock during the most recent fiscal quarter. This brings the total number of shares acquired by the company to 3,572, with a value of $28,000. Eaton Vance Management increased its holdings in 1Life Healthcare by a factor of 300.0% over the final three months of the previous year (2018). After purchasing an additional 2,892 shares of the company’s stock during the most recent quarter, Eaton Vance Management now has a total of 3,856 shares of ownership in the business. The total value of Eaton Vance Management’s stock holdings, as determined by today’s market, is $68,000.
Last but not least, US Bancorp DE increased its stake in 1Life Healthcare by 88.8 percent during the first three months of this year. US Bancorp DE now owns 4,492 shares in the company, which have a value of $50,000, thanks to the recent purchase of an additional 2,113 shares in the company during the most recent quarter. As a result, US Bancorp DE’s holdings in the company have increased by that amount. To the tune of 79.58% of the company’s shares, hedge funds and various other types of institutional investors are the owners of those shares.
On Friday, shares of NASDAQ: ONEM began trading for $17.15 per unit. The price of 1Life Healthcare may range anywhere from $5.94 to $24.59 over a year. The debt-to-equity ratio is 0.19, the current ratio is 2.59, and the quick ratio is 2.56. All three of these ratios are very similar to one another. The company’s market capitalization is currently at $3.35 billion, its price-to-earnings ratio is at -8.75, and its beta value is at 2.47. The moving average of the company’s stock price over the past 200 days is $12.01, while the moving average over the past 50 days is $17.13.
The most recent quarterly earnings report for 1Life Healthcare (NASDAQ: ONEM) was made public on August 3, 2013, a Wednesday. The company reported earnings per share for the quarter of $0.48, consistent with the consensus estimate of $0.48 among market analysts. While 1Life Healthcare’s return on equity was negative by 21.05%, and the company’s net margin was negative by 40.24%, the company’s return on total assets was positive. The numbers that market analysts anticipated for the company’s quarterly revenue ranged from $263.99 million to $255.84 million. The lower end of that range was $255.84 million. Sell-side research analysts think that 1Life Healthcare’s earnings for the current fiscal year will be -1.91 cents per share.
The membership-based primary care platform run by 1Life Healthcare, Inc. is known by its brand name, One Medical, and that name refers to it in marketing materials. In addition to the more conventional approaches, the company has developed a model for healthcare membership based on direct consumer enrollment and third-party sponsorship. Its membership strategy combines user-friendly digital health services accessible at any time of day or night with warm and friendly in-office care typically covered by health insurance programs. This combination is available at no additional cost to members.
Source: beststocks.com
